Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

DOID EFO MESH SNOMED PheWeb

H7_USEOFEYEANTIALLERGENS

conjunctivitis: Inflammation of the conjunctiva of the eye. [ NCIT:P378 ]

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC S01GX

43592

Check pre-conditions, main-only, mode, ICD version None

15484

Check minimum number of events

Min. number of events 3

15484

Include endpoints None

15484

H7_USEOFEYEANTIALLERGENS

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	14954	11576	3378
Unadjusted prevalence (%)	4.85	6.67	2.50
Mean age at first event (years)	38.64	39.30	36.40

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.01	0.75 [0.53, 1.07]	1.2e-1	404
15 years	0.00	0.60 [0.44, 0.82]	1.1e-3	205
5 years	0.00	0.92 [0.67, 1.28]	6.3e-1	73
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: H7_USEOFEYEANTIALLERGENS – Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
GWS hits: 7

Survival analyses between endpoints

↥

Plot

before Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)
after Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

↥